1. Primary cultures of chondrocytes from the Swarm rat chondrosarcoma were labelled with either [3Higlucosamine or ['4Clglucosamine, and hyaluronate synthesized by the cells was isolated from the cell layer. Parallel cultures were labelled with either [3Hlserine or [3Hilysine, and identical fractions were isolated from the cell layer. Some cultures were dual-labelled. 2. In cultures labelled with [3Hlserine for between 30min and 24 h and extracted with 4.0 M-guanidine, a procedure that solubilizes predominantly extracellular-macromolecules, small amounts of [3Hlserine-labelled molecules were found associated with the hyaluronate fraction purified from the extract by dissociative CsCl-density-gradient centrifugation and dissociative Sepharose CL-2B chromatography. About 75% of the [3Hlserine-labelled molecules in the fraction were specifically associated with hyaluronate, since they could be removed by prior treatment with proteinase-free Streptomyces hyaluronidase. The association of the [3Hiserine-labelled molecules with hyaluronate was non-covalent, since they could be separated from it by further centrifugation in CsCl density gradients containing 4M-guanidinium chloride and a zwitterionic detergent. 3. In other experiments the cultures were extracted with a sequential zwitterionic-detergent/guanidinium chloride procedure that completely solubilized the cell layer and enabled fractions containing newly synthesized cell-associated hyaluronate to be isolated. Zwitterionic detergent was present throughout. No [3Hilysine was incorporated into these fractions, irrespective of whether the cultures were pulsed concurrently with [3Hllysine and f14Clglucosamine or sequentially with 13H]lysine to prelabel the protein pool (24h) followed by [14C1-glucosamine to label hyaluronate (1h). 4. The results show that newly synthesized hyaluronate is not associated with covalently bound protein, and suggest that chain synthesis is initiated by a mechanism other than on to a core protein. Small amounts of P3Hlserine-labelled molecules are, however, non-covalently associated with extracellular hyaluronate. Their identity is at present unknown, but they are probably of low molecular weight.
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Hyaluronic acid is synthesized by chondrocytes and has an important structural role in forming proteoglycan aggregates in the extracellular matrix (Hascall, 1977) , and possibly a regulatory role in controlling the extent of proteoglycan synthesis by the cells (Mason, 1981) . The regulation of hyaluronate biosynthesis in chondrocytes may therefore itself : To whom correspondence should be addressed. § Present address: Department of Biochemistry, Rush Medical School, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL 60612, U.S.A. be important in the maintenance of normal cartilage function. One point where regulation could be exerted is at the initiation of synthesis of the hyaluronate chain. Other glycosaminoglycans synthesized by chondrocytes are initiated by transfer of a glycosyl residue to appropriate hydroxy amino acids in the proteoglycan core protein (Roden & Schwartz, 1975) . Purified hyaluronate from a number of sources, including hyaline cartilage (Cleland & Sherblom, 1977) , is associated with small amounts of protein (Sandson & Hammerman, Hammerman, 1968; Swann, 1968 : Laurent. 1970 Greiling et al., 1970; Mathieson & Pearce, 1977 : Mikuni-Takagaki & Toole, 1981 . It has been proposed that the association may be covalent, and therefore indicative of a core protein, because it was maintained when hyaluronate was sedimented in CsCI density gradients containing 4.0M-guanidinium chloride and during other dissociative procedures (Scher & Hammerman, 1972; Mikuni-Takagaki & Toole, 1981 ). An alkali-labile O-glycosidic linkage between hyaluronate and protein, such as exists for chondroitin sulphate chains (Muir, 1958) , has not been identified, however (Varma et al., 1974 (Varma et al., , 1975 . Mikuni-Takagaki & Toole (1981) proposed that a putative hyaluronate-core-protein complex may have a long intracellular existence before glycosylation. They suggested that after glycosylation the hyaluronate-protein complex is bound to the cell surface, the free glycosaminoglycan being released into the extracellular compartment by proteolytic scission. Using an experimental protocol designed to test this hypothesis, they found that 13Hlleucine-labelled protein was associated with hyaluronate extracted from the cell layer of fibroblast cultures with guanidinium chloride.
Primary cultures of chondrocytes from the Swarm rat chondrosarcoma are active in synthesizing both proteoglycans (Kimura et al., 1979) and hyaluronate (Mason et al., 1982) . Pulse-chase experiments show that newly synthesized molecules of both types pass out of the cellular compartment into the cell-layer matrix, and finally into the medium (Kimura et al., 1979; Mason et al., 1982) . These experiments also demonstrate that extraction of the cell layer of cultures with 4 M-guanidinium chloride effectively solubilizes extracellular, but not significant amounts of intracellular, proteoglycan and hyaluronate. In contrast, sequential treatment of the cell layer with the zwitterionic detergent ZwittergentTM 3-12 and 4 M-guanidinium chloride completely solubilizes both cell-associated and extracellular macromolecules (Kimura et al., 1981) . Using duallabelling techniques, including protocols similar to those described by Mikuni-Takagaki & Toole (1981), we have employed these selective extraction techniques to investigate the association of 3H-labelled protein with newly synthesized hyaluronate in the cell layer of chondrocyte cultures. In a first series of experiments in which cultures were labelled with 13Hiserine, small amounts of non-covalently linked 3H-labelled molecules were shown to be specifically associated with extracellular hyaluronate. In the second series of experiments cells were labelled with high-specific-radioactivity 1 3Hilysine, and the cell layer was extracted with the Zwittergent/ guanidine procedure. No 3H-labelled molecules, and therefore no core protein, could be shown to be associated with the hyaluronate fraction. Na235SO4 (800mCi/mmol of S; Amersham International) or dual-labelled with Na235SO4 and one of the 3H-labelled compounds. Medium from which unlabelled serine and inorganic sulphate had been omitted was used for labelling, as described previously (Mason et al., 1982) . In some experiments duplicate cultures were labelled separately with [3Hlglucosamine and 3H Iserine.
In the second series of experiments, three different protocols were used to label cells with L- [4,5- 3Hllysine (108 Ci/mmol; Amersham International) in lysine-free medium. In the first protocol, day-I cultures were pulsed with Amersham International) in medium containing 15% serum. In the second protocol, day-3 cultures were dual-labelled for 24h either with [3Hllysine and Na235SO4 or with [3H1-glucosamine and Na235SO4. In a third protocol day-3 cultures were labelled for 24 h with [3HI-lysine, the medium was removed and the cells were pulsed with ['4C ]glucosamine in fresh medium for a further 1h. In the experiments in which day-3 cultures were used, the medium for maintenance and labelling was changed from day 2 to Dulbecco's modified Eagle's medium containing 2% (v/v) foetal calf serum and lOOng of insulin/ml (d 'Arville & Mason, 1981) . This medium minimizes artifacts arising from the non-specific association of glucosamine with serum proteins (Mason et al., 1982) while maintaining conditions for proteoglycan and hyaluronate synthesis.
Extraction ofcell layers
In the first series of experiments the cell layer was extracted with 4.0M-guanidinium chloride in 50mM-sodium acetate buffer, pH5.8, containing the proteinase inhibitors 6-aminohexanoic acid (0.1 M), benzamidine hydrochloride (5 mM) and disodium EDTA (10mM) for 1 h at 40C with gentle agitation.
In the second series of experiments, the cell layer was extracted for 30min with 8% ZwittergentTM3-l2 (Calbiochem-Behring Corp.), after which an equal volume of 8 M-guanidinium chloride was added and the extraction was continued for a further 30min at 4°C with gentle agitation. The extraction was then repeated with fresh 4M-guanidinium chloride, and the two extracts were pooled (Kimura et al., 1981) . In addition to the proteinase inhibitors above, extracts in the second series also contained phenylmethanesulphonyl fluoride (1 mM) and N-ethylmaleimide (1 mM). Any residue remaining on the plates after the extraction was dissolved in 0.5 M-NaOH (18 h, 200C) and its radioactivity measured.
Equilibrium density-gradient centrifugation After the addition of carrier proteoglycan (final concn. approx. I mg/ml) extracts were chromatographed on PD-10 columns (Pharmacia) eluted with 4 M-guanidinium chloride, to remove unincorporated radioactivity (Mason et al., 1982) . For the second series of experiments the columns were equilibrated and eluted with 4 M-guanidinium chloride containing 4% Zwittergent and proteinase inhibitors. Solid CsCI was added to the void-volume fraction to give a density of 1.43 g/ml and the solutions were centrifuged in either a 6 x 5 ml rotor (Beckman SW50. 1) or a 3 x 6.5 ml rotor (MSE no. 43127-102) at 37000rev./min for 48h at 10°C. Each gradient was fractionated as described previously. and individual fractions were pooled to give fractions D1-D4 (Mason et al., 1982) . These were dialysed twice against an excess of 4 Mguanidinium chloride to remove CsCl. The densities of the fractions were as shown in Fig. 2 (Bitter & Muir, 1962) . The column was conditioned by pumping 2.5 mg of rat chrondrosarcoma aA1 proteoglycan fraction (Faltz et al., 1979) al., 1982) . Total 3H-labelled chondroitin sulphate is expressed as the sum of the 3H radioactivities for the unsaturated disaccharides Adi-6-S + Adi-4-S + Adi-0-S (Mason et al., 1982) . Treatment of fractions with Streptomyces hvaluronidase Carrier hyaluronate (final concn. 1 mg/ml; type I, Miles Biochemicals) was added to fractions before dialysis against 100vol. of 50mM-sodium acetate buffer, pH 5.0. Portions (0.5 ml) were then digested with Streptomyces hyaluronidase (CalbiochemBehring Corp.; 20 turbidity-reducing units/digest, 600 C, 18 h) in the presence of 0.1 M-6-aminohexanoic acid, 5 mM-benzamidine hydrochloride and 10mM-disodium EDTA. In some experiments a preparation of proteinase-free hyaluronidase (Caputo et al., 1980) was used, in which case the proteinase inhibitors were omitted. The incubation was terminated by the addition of an equal volume of 8 M-guanidinium chloride (containing 4% Zwittergent where appropriate).
Results and discussion
Association of P3Hiserine-labelled protein with the hyaluronate fraction extracted from cultures with guanidinium chloride
After labelling of chondrocyte cultures with [3Higlucosamine for 30min, about 30% of the 3H-labelled hyaluronate synthesized is found in the cell-layer extract and medium (Mason et al., 1982) . Whether newly secreted hyaluronate is associated with protein was investigated by labelling duplicate cultures (6 x 106 cells) for 30min either with 13Hi-glucosamine plus Na235SO4 (125 ,uCi/mi and 50 ,uCi/ml respectively) or with 1 3Hiserine plus Na235SO4 (125,uCi/ml and 50,uCi/ml respectively).
After removal of the medium, the cell layers were extracted with 4M-guanidinium chloride containing proteinase inhibitors, and the extracts were passed through a PD-1O column to remove unincorporated labelled precursor. 3H-labelled hyaluronate formed 14.7% of the total 3H-labelled glycosaminoglycan fraction in the cell-layer extract, as determined by chondroitinase ABC digestion and disaccharide analysis. The cell-layer extracts were centrifuged in dissociative density gradients, and a D2 fraction was isolated (Figs. la and lc). Previous results (Mason et al., 1982) indicated that 90% of the 3H-labelled hyaluronate in the cell-layer extract bands in the D2 fraction under these conditions. The D2 fractions The D2 fractions of both cultures contained about 10% of the total 31S radioactivity in the gradient, and the chromatographic profiles suggest that this was due to the presence of two partially separated proteoglycan species that were included within the column. In the D2 fraction from the culture labelled with [3Hlglucosamine, 59% of the 3H-radioactivity was eluted in the void fraction of the column, clearly separated from the 35S-labelled proteoglycan. Chondroitinase ABC digestion and disaccharide analysis of the void-volume fractions obtained by the same methods from other cultures labelled with PHlglucosamine showed the presence almost solely of 3H-labelled hyaluronate (see below). The D2 fraction from the culture labelled'withh Hlserine also showed 1~~~~~~~~~~~~~~~~~~~~. 3 a small 3H-labelled peak .1uted in the void fraction (Fig. Ib) . It accounted for 2% of the total 3H label in the D2 fraction and was'cfearly resolved from the proteoglycan. This suggested' that a small amount of [3Hlserine-labelled protein may be associated with the hyaluronate.
Larger cultures were labelled either with P3HI-glucosamine (50,uCi/ml) or with [ 3Hiserine (50uCi/ ml) for either 6h or 20b, the media and cell-layer extracts were fractionatedinto D1-D4 fractions by Fig. 2(b) .
Analyses of gradients prepared from the media from cultures labelled for 6 h and from both the media and cell-layer extracts of the cultures labelled for 20h gave nearly identical results (results not shown). The amounts of 3H-labelled hyaluronate present in the D 1-D4 fractions for the culture labelled with [3Hlglucosamine were measured, and the relative distribution is indicated in Fig. 2(a) , along with the distribution of label for fractions from the culture labelled with [3Hlserine. About 1-2% of the 3H label in the D2 fraction of the culture labelled with
[3Hlserine was eluted in the Sepharose CL-2B void volume. The same proportion was eluted in this position when a portion of the D2 fraction was chromatographed in the absence of carrier aA 1 proteoglycan (see the Experimental section). Thus aggregation of 3H-labelled molecules present in the D2 fraction with the small amount of hyaluronate in the carrier is unlikely to be responsible for the 3H radioactivity in the void fraction. As for the experiment in Fig. 1(d (Fig. 2a) . Only 0.3% of D3-fraction and 3.8% of D4-fraction [3H]serine radioactivity is eluted in the void fraction of Sepharose CL-2B (Fig. 2b) . The D4-fraction profile, in particular, shows that the cells synthesize some proteins that are eluted in the void volume of Sepharose CL-2B, presumably as aggregates formed though protein-protein association, through protein-lipid micelle formation or by interaction with the hyaluronate in the carrier aA 1 proteoglycan with which they were chromatographed.
Susceptibility of [3Hlserine-labelled molecules in the hyaluronatefraction to Streptomyces hyaluronidase A portion of the [3H]serine-labelled cell-layer extract from the 6h culture, containing 1.0mg of carrier aA1 proteoglycan, was chromatographed on a PD-10 column to remove unincorporated labelled precursor. It was then chromatographed on Sepharose CL-2B in 4 M-guanidinium chloride, and the void-volume fraction was collected. This fraction was then centrifuged under dissociative conditions in a CsCl density gradient. Of the 3H radioactivity in the gradient 19% was recovered in the D2 fraction (densities 1.42-1.53g/ml). The initial concentration of hyaluronate in the gradient was approx. 2,ug/ml, or less. After the addition of 5 mg of carrier hyaluronate, the D2 fraction was dialysed exhaustively and concentrated in a dialysis bag against dry Sephadex G-200. A sample was mixed with an equal volume of 8 M-guanidinium chloride and chromatographed on Sepharose CL-2B. Another was incubated overnight with proteinase-free Streptomyces hyaluronidase, then mixed with an equal volume of 8 M-guanidinium chloride and chromatographed on the same column. The column profiles, together with those of controls, are shown in Fig. 3 . Of the 3H radioactivity of the untreated fraction 72% was eluted in the void fraction of the column. After digestion with hyaluronidase, only 23% of the 3H radioactivity was found in the excluded fraction, the remainder being recovered mainly in fractions 40-60. A control composed of 2.5 mg of carrier hyaluronate mixed with a sample of relatively-low-molecular-weight 3H-labelled hyaluronate isolated from fibroblast cultures (Caputo et al., 1980) (Fig. 3c) was degraded completely by the hyaluronidase (Fig. 3d) . The elution profile of a [3Hiserine-labelled Dl fraction of Sepharose CL-2B was virtually identical before (Fig. 3e) and after ( Fig. 3f) incubation with hyaluronidase, indicating the absence of any proteinase activity. About 9% of the 3H radioactivity of the untreated D l fraction was eluted just ahead of the Vt of the column. This radioactivity probably represents a spill-over of the prominent 3H-labelled component in the D2 fraction that is eluted in this area of the chromatograph (see Fig. 2b ). After treatment of the Dl fraction with the hyaluronidase, about 13% of the 3H radioactivity was recovered in this fraction. This small difference is probably within the experimental reproducibility of the column technique, although it may reflect the presence of a small amount of hyaluronate in DI fractions (Fig. 2a) from which associated [3Hlserine-labelled molecules would move into the column after hyaluronidase treatment. The results of the experiment show that approx. 70% of the [3H]serine-labelled molecules eluted in the V0 fraction (Fig. 3a) are associated with high-molecular-weight hyaluronic acid and are no longer eluted in this fraction if the latter is degraded with the specific hyaluronidase (Fig. 3b) . (Fig. 4a ) were pooled. CsCl was then added to a density of 1.42g/ml, and the solution was centrifuged under dissociative conditions without further addition of carrier. It was estimated that the initial carrier hyaluronate concentration in the centrifuge tube (from addition of aAl proteoglycan to the original cell-layer extract and to the preparative chromatography step) was less than 20,ug/ml. The results are shown in Fig. 4(b) . Only 22% of the 3H radioactivity in the gradient (about 0.05% of the total in the original extract) formed a band in the density range 1.4 1-1.52g/ml (fractions 7-1 1), even though this corresponded exactly to the original D2 fraction of the cell-layer extract and to the density range in which 90% of the hyaluronate bands under dissociative conditions (Fig. 2a) 1.43 g/ml before centrifugation for 96 h to obtain a D2-D2 fraction (see the Experimental section). The centrifugal conditions were designed to separate high-density proteoglycan and most of the protein from hyaluronate in the flrst run, and to band the remaining protein in the top of the gradient and hyaluronate in the bottom of the gradient in the second run.
The dissociative Sepharose CL-2B profile of D2-D2 fraction from the 13Hlglucosamine-labelled culture shows a prominent peak, characteristic of 3H-labelled hyaluronate, in the void-volume fraction of the column ( in Fig. 5a ). In contrast, 3H radioactivity recovered in the void-volume fraction of D2-D2 fraction from the [3Hlserine-labelled culture accounted for less than 0.3% of the 66000d.p.m. of 3H radioactivity recovered from the column ( in Fig. 6b ). Therefore after prolonged dissociative centrifugation in the presence of Zwittergent extracellular hyaluronate can be prepared free of 3H radioactivity incorporated from [3Hiserine.
Extraction of cell-layer macromolecules with Zwittergent and guanidinium chloride Extraction of the cell layer with 4% Zwittergent and 4M-guanidinium chloride completely solubilizes both intra-and extra-cellular macromolecules synthesized by the cell cultures (Kimura et al., 1981) .
Since the experiment above shows that these ['5Slsulphate . After the addition of Zwittergent, the D2 fractions were centrifuged in a dissociative gradient, and D2-D2 fractions were isolated. Dissociative Sepharose CL-2B elution profiles are shown for D2-D2 fractions from (a) a culture labelled with [3Hlglucosamine ( ) and ['5Slsulphate (...) . and from (b) a culture labelled with [3Hiserine ( ) and 315Slsulphate (. ) . For full experimental details see the text.
reagents effectively dissociate all labelled proteins from extracellular hyaluronate, a further set of experiments was performed to investigate whether any non-dissociable protein could be detected in the cell-associated hyaluronate pool. High-specificradioactivity [3Hllysine in lysine-free medium was used to label protein in these experiments to enhance the possibility of detecting synthesis of minor components of the total polypeptide pool. Chondrocyte cultures were labelled for 1 h with [3Hllysine (125,uCi/ml) and [14Clglucosamine (25 pCi/ml), and the cell layer was extracted with the Zwittergent/guanidine procedure; 98% of the [14Clglucosamine-labelled macromolecules in the cell layer were extracted. The extract was centrifuged in a dissociative CsCl density gradient containing 4%
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Zwittergent, and the D2 and D3 fractions of the gradient were obtained and chromatographed on a Sepharose CL-2B column equilibrated with 4 Mguanidinium chloride in 50mM-sodium acetate buffer, pH5.8, containing 0.1% Zwittergent (Fig. 6) . A "4C-labelled peak was eluted in the void volume of the column for both D2 fraction and D3 fraction. Although 4.6 x 104d.p.m. of 3H radioactivity was recovered from the column for D2 fraction (Fig. 6a ) and 3.3 x 105d.p.m. of 3H radioactivity for D3 fraction (Fig. 6b) , none was eluted in the void volume. About 75% of the hyaluronate synthesized by chondrocyte cultures during a 30min period is associated with the residue remaining after extraction of the cell layer with 4M-guanidinium chloride, and pulse-chase experiments show that these mol- ecules are all cell-associated (Mason et al., 1982) .
Even after a 2h pulse about 40% of the hyaluronate synthesized is cell-associated (Mason et al., 1982) . Thus in the present experiment, where a I h pulse was used and the Zwittergent/guanidine procedure was employed to solubilize the cell layer completely, at least 50% of the 14C-labelled hyaluronate in the extract would come from the cell-associated pool.
Nevertheless, there is no evidence that any PHIlysine was incorporated into macromolecules that were bound to hyaluronate synthesized under these solvent conditions. Mikuni-Takagaki & Toole (1981) have proposed that hyaluronate synthesis is initiated by glycosylation of a long-lived protein acceptor, bound to the endoplasmic-reticulum membrane, and that the completed glycosaminoglycan chains are released into the extracellular compartment by proteolytic action after the complex has moved to the cell surface. Thus in experiments with a short pulse period it is possible that labelled hyaluronate may represent chains elongated on a pre-existing unlabelled core protein.
We have therefore examined hyaluronate synthesis in cultures pulsed with P3Hilysine (125,uCi/ml) for 24h to ensure that any putative hyaluronate-coreprotein complex synthesized during this period would be labelled. Parallel cultures were labelled with 13Higlucosamine and [35Slsulphate. The Zwittergent/guanidine extraction solubilized more than 98% of the total 13HIglucosamine-labelled macromolecules present in the cell layer after the 24h label. The D2 and D3 fractions were isolated and chromatographed on a dissociative Sepharose CL-2B column. Fig. 7(a) shows the chromatographic profile for D2 fraction. A prominent 3H-labelled peak in the void volume of the column was completely eliminated by prior treatment with Streptomyces hyaluronidase in the presence of proteinase inhibitors (Fig. 7b) , showing that the peak is due to 3H-labelled hyaluronate. Furthermore. the increase in 3H radioactivity eluted in fractions 46-58 of the column after hyaluronidase treatment (stippled area in Fig. 7b ) exactly matched the loss of 3H radioactivity in fractions 16-24. Since Streptomyces hyaluronidase specifically degrades hyaluronate to tetra-and hexa-saccharides (Ohya & Kaneko, 1970; Hatae & Makita, 1975) , which would be eluted in the total column volume (Vi), this result indicates that fractions 16-24 contain all the 3H-fabelled hyaluronate present in D2 fraction. When the D2 fraction from the parallel culture labelled with [3Hllysine was chromatographed on the same column, only background radioactivity was detected in fractions 16-24 (Fig. 7c) . The D3 fractions from the cell-layer extracts gave similar profiles on dissociative chromatography (results not shown), with only background 3H radioactivity in the void volume for the [3Hllysine-labelled sample. Less than 20% of the total 3H-labelled hyaluronate synthesized during a 24h period remains in the cell layer at the end of the pulse (Mason et al., 1982) . That which does is all of very high molecular weight, and must represent molecules synthesized throughout the period that are specifically retained in the cell layer, together with molecules synthesized during the latter part of the pulse, but not yet lost to the medium. The results of this experiment show that no 3H-labelled protein synthesized during the 24 h period is covalently associated with this pool of hyaluronate.
In another experiment cultures were labelled for 24 h with [3Hllysine (125 ,uCi/ml), after which the medium was replaced with one containing [14Cl-glucosamine (25,uCi/ml) and incubation was continued for a further 1 h. This protocol is similar to that described by Mikuni-Takagaki & Toole (1981) to label putative hyaluronate-core-protein complex.
After solubilization of the cell layer by the Zwittergent/guanidine procedure, the extract was fractionated by dissociative centrifugation in the presence of Zwittergent, and the D2, D3 and D4 fractions from the gradient were chromatographed on a Sepharose CL-2B column (Fig. 8) . Fraction D2 had a '4C-radioactivity peak in the void volume, but only background 3H radioactivity was eluted in the same fractions (Fig. 8a) . The '4C-labelled void-volume peak was completely eliminated by prior treatment with hyaluronidase (results not shown). Fraction D3 also had a small '4C-radioactivity peak in the void volume of the chromatogram, together with a very small 3H-labelled peak in the same position. The profile was unchanged by prior dialysis against excess 50mM-acetate buffer (Fig. 8b) , but the '4C-radioactivity peak in the void volume was eliminated by digesting the dialysed fraction with hyaluronidase ( Fig. 8c) . However, the 3H-labelled void-volume peak was not affected by the enzyme (Fig. 8c, inset ) and constituted the same proportion of total 3H radioactivity (0.7%) in D3 fraction as
Vol. 207 was found before digestion. The 3H-labelled voidvolume peak in D3 fraction in this experiment was therefore not associated with hyaluronate. It may be due to a spill-over into D3 fraction of very large 3H-labelled molecules normally present in the voidvolume fractions of D4 fraction ( Fig. 8d, inset; note the difference in scale), Only background 14C radioactivity was present in the void volume of the D4-fraction elution profile (Fig. 3d) , and in any case this fraction contains virtually no hyaluronate of any molecular weight, as shown by specific disaccharide analysis (Mason et al., 1982) .
'4C-labelled hyaluronate recovered in the void volume of Sepharose CL-2B columns in the last experiment represents synthesized high-molecularweight molecules. A high proportion of these would be expected to be cell-associated after only a 1 h labelling period, as discussed above, and should still be covalently linked to 3H-labelled hyaluronate-coreprotein complex, according to the Mikuni-Takagaki & Toole (1981) hypothesis. Moreover, any 3H-labelled hyaluronate-core protein complexes synthesized before the [(4C]glucosamine pulse, but still associated with the cell layer after it, would also contribute to 3H radioactivity in the void-volume fractions. At the beginning of the ['4Clglucosamine pulse over 6 x 107d.p.m. of 3H radioactivity was present in the cell layer. If up to 95% of this radioactivity was extracellular, there would still be 3 x 106 d.p.m. of 3H radioactivity incorporated into intracellular polypeptides. Thus, even if a hypothetical hyaluronate-core-protein complex accounted for as little as 0.1% of this intracellular radioactivity, it would still have 3000d.p.m. of 3H radioactivity associated with it, an amount that would have been readily detectable in our experiments. However, only background 3H radioactivity was found in the void-volume fractions for D2 fraction, and the very small peaks of 3H radioactivity in similar fractions from D3 and D4 fractions were not associated with hyaluronate.
General discussion
The chondrocyte cultures used for the present investigation are particularly suitable for the study of differences in intracellular and extracellular hyaluronate. The cells are active in hyaluronate synthesis, and previous experiments show that only extracellular hyaluronate (Mason et al., 1982) and proteoglycans are extracted from the cell layer with 4.0OM-guanidinium chloride.
Radioautographic studies on cartilage after labelling with [35S]sulphate also support this proposal (Hardingham & Muir, 1972 (Swann, 1968) , a hyaluronate preparation from rooster comb, is similar to that of hyaluronate isolated from bovine nasal-septum cartilage (Cleland & Sherblom, 1977) , suggesting the hyaluronate from widely differing sources may be associated with a similar protein component.
In the second series of experiments, in which cultures were labelled with [3Hllysine, the cell layers were extracted with 4M-guanidinium chloride and 4% Zwittergent, a procedure that completely solubilizes intracellular as well as extracellular macromolecules (Kimura et al., 1981 (Niedermeier & Gramling, 1970 (Appel et al., 1979) . A possible mechanism may therefore involve chain elongation on to a small carbohydrate precursor, although attempts to identify such a molecule have not yet been successful (Sugahara et al., 1979; Appel et al., 1979) . A further possibility is that a non-covalent protein 'primer' may be involved in initiating hyaluronate synthesis, in a manner analogous to the role of a-lactalbumin (Ginsburg & Stadtman, 1970) in the synthesis of lactose and milk oligosaccharides.
